INTELLIA THERAPEUTICS, INC. (NTLA) Free cash flow 2016–2025
INTELLIA THERAPEUTICS, INC. (NTLA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$395.9MFY2025 · since FY2016: $29.9M → -$395.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$395.9M | -11.6% |
| FY2024 | -$354.7M | +13.1% |
| FY2023 | -$408.1M | -17.7% |
| FY2022 | -$346.8M | -45.9% |
| FY2021 | -$237.8M | -344.5% |
| FY2020 | -$53.5M | +51.4% |
| FY2019 | -$110.0M | -62.7% |
| FY2018 | -$67.6M | +10.3% |
| FY2017 | -$75.4M | -351.7% |
| FY2016 | $29.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice